Yasuhiro Suzuki, Toshiyuki Yamamoto. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AgedCollagen Diseases/chemically inducedCollagen Diseases/drug therapyCollagen Diseases/pathologyDiabetes Complications/complicationsDrug Eruptions/etiologyErlotinib HydrochlorideHumansMaleProtein Kinase Inhibitors/adverse effectsQuinazolines/adverse effectsSkin Diseases/chemically inducedSkin Diseases/drug therapySkin Diseases/pathology
Substances: See more » Protein Kinase InhibitorsQuinazolinesErlotinib Hydrochloride
Year: 2012 PMID: 22101862 DOI: 10.2340/00015555-1248
Source DB: PubMed Journal: Acta Derm Venereol ISSN: 0001-5555 Impact factor: 4.437